Evaluation of the Immunogenicity of Vaccination With HER-2/Neu and CEA [carcinoembryonic antigen] Derived Synthetic Peptides With GM-CSF [granulocyte macrophage colony-stimulating factors]-in-Adjuvant, in Patients With Stage IIB, III, or IV Colorectal Cancer
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Colorectal cancer vaccine; Montanide ISA-51; Sargramostim
- Indications Colorectal cancer
- Focus Therapeutic Use
- 30 Mar 2020 Biomarkers information updated
- 23 Jul 2008 Status changed from recruiting to in progress based on information from ClincialTrials.gov.
- 29 Oct 2005 New trial record.